Newly discovered genetic variations linked to autism spectrum disorder (ASD) disrupt the function of the dopamine transporter, suggesting that altered dopamine signaling contributes to this common developmental condition, according to a Vanderbilt University-led research team.

Stephen Camarata, Ph.D., professor of Hearing and Speech Sciences, has been honored by Autism Speaks, a national autism advocacy and research organization, for dedicated service.

Amy Weitlauf, Ph.D., assistant professor of Pediatrics, will be leading a study among parents of children with autism spectrum disorder (ASD) to examine the effectiveness of mindfulness training as part of early interventions for children with ASD.

The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.

Vanderbilt University researchers have received multi-year grants from two private foundations to investigate key signaling proteins that could lead to novel treatments for autism spectrum disorder (ASD) and dystonia, a movement disorder.

The Vanderbilt Kennedy Center is launching is a new educational series that will focus on the complexities of conducting interdisciplinary research and clinical trials that involve behavioral, environmental and pharmaceutical interventions.